USPTO serial 90792354
EG 427 PINPOINT GENE THERAPY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 27, 2022
- Examiner
- JARAMILLO, JAVIER R
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EG 427 PINPOINT GENE THERAPY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina Campagna
Pina Campagna CARTER, DELUCA AND FARRELL LLP576 BROAD HOLLOW RD.MELVILLE, NY 11747UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and biochemical preparations for scientific and research purposes; reagents for scientific and research purposes; chemical preparations and chemical reagents for industrial, agri-food, cosmetic, pharmaceutical and environmental purposes, other than for medical or veterinary use; Stem cells for research purposes; Bacterial, bacteriological, biological and chemical preparations for scientific purposes other than for medical or veterinary use | ACTIVE | — |
| 005 | Pharmaceutical preparations for use as treatments of neurological pathologies; biological tissue cultures for medical purposes; albuminous preparations for medical purposes; chemical preparations for use as treatments of neurological pathologies; Chemical and biological reagents for medical, pharmaceutical or veterinary purposes; reagents and culture media for in vitro medical, pharmaceutical or veterinary diagnosis; Pharmaceutical preparations for human use for the treatment of neurological pathologies; Bacterial, bacteriological, biological and chemical preparations for medical and therapeutic purposes, namely, for treatment of neurological pathologies | ACTIVE | — |
| 010 | Surgical apparatus and instruments for medical or veterinary use; therapeutic and assistive devices to diagnose or administer treatments for cardiovascular, digestive, endocrine, genitourinary, genetic, hematological, immune, infectious, neurological, oncologic, respiratory, sight, hearing, pulmonary and skin diseases, designed for people with disabilities; In vitro diagnostic apparatus and instruments for medical, pharmaceutical or veterinary use in the field of gene therapy for diagnosis of cardiovascular, digestive, endocrine, genitourinary, genetic, hematological, immune, infectious, neurological, oncologic, respiratory, and skin diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GENELPIS
- Other trademarks owned by EG427
- Other trademarks owned by EG427
- Other trademarks owned by EG427
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named EG 427 PINPOINT GENE THERAPY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 27, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 27, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 11, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 11, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 21, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 7, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Sep 2, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Aug 26, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 23, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 22, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 22, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 4, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Sep 9, 2021 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 28, 2021 | NWAP | NEW APPLICATION ENTERED | — |